u/solene_abubakar

Correction: that stability figure covers the lyophilised powder, not the reconstituted solution. Different claim entirely.

Buying small from an unfamiliar supplier and testing before committing is the single procedural change that would have prevented the largest share of financial losses described on this board.

That is a lane problem rather than a packaging problem, and the fixes are different.

compare cash prices before assuming coverage is the only path

Are you comparing against a GLP-1 monotherapy result? They are not comparable.

Has the appetite changed, even if the scale has not?

I confused two very similar words on my first order and asked here, expecting to be mocked. Three people explained it properly instead.

phase 3 data will change most of what gets said here

How long did it take you to notice?

Health Canada approval is not coverage

keep every form, every date, every reference number

Yes. Approval and coverage are separate, and this board conflates them in about half its threads.

Gently disagree with the framing — nothing has gone wrong. Week 12 looking flat is the ordinary experience.

Correction: that is the combination programme, not the monotherapy readout. Different arms, different numbers.

That result is preclinical. Worth flagging, since the thread has been reading it as human data.

Read the combination paper twice before saying anything here. The monotherapy and combination arms tell genuinely different stories.

Concentration is mass over volume, and a U-100 syringe reads 100 units per millilitre. Those two facts are the whole of the arithmetic this board keeps explaining.

Most of what gets posted here is procedural rather than dramatic: a step skipped, a document not requested, a temperature not considered, a pace chosen out of impatience.

Cosigning that going too fast is the most repeated regret on the whole site.

accusing the wrong party and correcting it publicly is the best kind of post here

regional stock removes most of this problem entirely

the thing that went wrong is usually procedural, not dramatic

Stopped for financial reasons and regained most of it. Not a moral story, just a budget and a documented outcome.

buy small first is the lesson that keeps being learned expensively

This is the answer.

Slight disagreement with this bit only, because a beginner reading it might take it as a plan rather than a description.

this board exists so the failures are on the record too

ask the pharmacy what the cash price is, it varies

What does the wiki page on this say — genuinely asking, not deflecting?

regional stock removes most of this problem entirely

special authorization forms are published, read them before applying

this is a less-travelled board and the evidence base shows it

stopping for financial reasons is not a personal failure

powder at room temperature for a few days is usually a non-event

Yes. Buy small first. It is the cheapest lesson on the site and it keeps being learned the expensive way.

stopping for financial reasons is not a personal failure

Moved provinces and the coverage position changed completely. Same person, same history, different formulary.

Agreed on seasonality. The same lane in February and August is not the same lane.

write the reconstitution date on the vial

going up too fast is the most repeated regret on this board

research-use-only material is not approved for human use, and that belongs in every beginner thread